The prognosis of TP53 and EGFR co-mutation in patients with advanced lung adenocarcinoma and intracranial metastasis treated with EGFR-TKIs

BackgroundTP53 mutation is a poor factor for non-small cell lung cancer (NSCLC), while the effect of TP53 on prognosis in epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma (LUAD) with brain metastasis remains elusive and needs further exploration.MethodsWe retrospectively analyzed...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Weiguo Gu, Penghui Liu, Jiaming Tang, Jianfei Lai, Siya Wang, Jiaming Zhang, Jinbiao Xu, Jianxiong Deng, Feng Yu, Chao Shi, Feng Qiu
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2024-02-01
Edice:	Frontiers in Oncology
Témata:	lung cancer brain metastasis EGFR TP53 prognosis
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1288468/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!